{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T02:10:56Z","timestamp":1759803056108,"version":"build-2065373602"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,6]]},"DOI":"10.7759\/cureus.93975","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T01:41:35Z","timestamp":1759801295000},"source":"Crossref","is-referenced-by-count":0,"title":["A Comparative Analysis of Resistance Patterns in Rifampin-Resistant Tuberculosis: Mutations Within and Outside the Rifampicin Resistance-Determining Region"],"prefix":"10.7759","author":[{"given":"Haris","family":"Saeed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Adnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tayyeba","family":"Komal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sana","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Kashif Munir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"World Health Organization. Global Tuberculosis Report 2024. (2024). Accessed. September 05, 2025: https:\/\/www.who.int\/publications\/i\/item\/9789240101531."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.15212\/ZOONOSES-2024-0061","article-title":"Decoding the WHO global tuberculosis report 2024: a critical analysis of global and Chinese key data","volume":"5","author":"Chen Z","year":"2025","unstructured":"Chen Z, Wang T, Du J, et al.. Decoding the WHO global tuberculosis report 2024: a critical analysis of global and Chinese key data. Zoonoses. 2025, 5:999. 10.15212\/ZOONOSES-2024-0061","journal-title":"Zoonoses"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.53555\/jaz.v45i5.4785","article-title":"Treatment outcomes of drug resistant tuberculosis patients: a retrospective analysis of data from 2012 to 2022","volume":"45","author":"Munir MK","year":"2024","unstructured":"Munir MK, Rehman S, Raza FA, Hanif A, Aasim M, Nazir MA. Treatment outcomes of drug resistant tuberculosis patients: a retrospective analysis of data from 2012 to 2022. J Adv Zool. 2024, 45:213-9. 10.53555\/jaz.v45i5.4785","journal-title":"J Adv Zool"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1101\/2025.05.06.25327063","article-title":"Self-collected finger-prick blood for gene expression profiling: unveiling early immune responses in mild COVID-19","author":"Thi\u00e9baut R","year":"2025","unstructured":"Thi\u00e9baut R, Lhomme E, Hocini H, et al.. Self-collected finger-prick blood for gene expression profiling: unveiling early immune responses in mild COVID-19. medRxiv. 2025, 10.1101\/2025.05.06.25327063","journal-title":"medRxiv"},{"key":"ref5","unstructured":"National TB Elimination Program (NTEP). PCR amplification of the target genes in Truenat. (2024). Accessed. September 18, 2025: https:\/\/ntep.in\/node\/1539\/CP-pcr-amplification-target-genes-truenat."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2217\/fmb.11.84","article-title":"Xpert\u00ae MTB\/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance","volume":"6","author":"Lawn SD","year":"2011","unstructured":"Lawn SD, Nicol MP. Xpert\u00ae MTB\/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance. Future Microbiol. 2011, 6:1067-82. 10.2217\/fmb.11.84","journal-title":"Future Microbiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0277145","article-title":"High proportion of RR-TB and mutations conferring RR outside of the RRDR of the rpoB gene detected in GeneXpert MTB\/RIF assay positive pulmonary tuberculosis cases, in Addis Ababa, Ethiopia","volume":"17","author":"Akalu GT","year":"2022","unstructured":"Akalu GT, Tessema B, Petros B. High proportion of RR-TB and mutations conferring RR outside of the RRDR of the rpoB gene detected in GeneXpert MTB\/RIF assay positive pulmonary tuberculosis cases, in Addis Ababa, Ethiopia. PLoS One. 2022, 17:e0277145. 10.1371\/journal.pone.0277145","journal-title":"PLoS One"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.54112\/bcsrj.v2022i1.165","article-title":"Comparison of Genexpert\u00ae probe missing in hotspot RRDR of rpoB gene among Primary and Acquired drug resistant cases of pulmonary tuberculosis","volume":"3","author":"Munir MK","year":"2022","unstructured":"Munir MK, Shamim S, Rehman S, Hanif A, Saeed MS. Comparison of Genexpert\u00ae probe missing in hotspot RRDR of rpoB gene among Primary and Acquired drug resistant cases of pulmonary tuberculosis. Biol Clin Sci Res J. 2022, 3:165. 10.54112\/bcsrj.v2022i1.165","journal-title":"Biol Clin Sci Res J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-019-00763-3","article-title":"Optimal sampling strategies for therapeutic drug monitoring of first-line tuberculosis drugs in patients with tuberculosis","volume":"58","author":"Saktiawati AM","year":"2019","unstructured":"Saktiawati AM, Harkema M, Setyawan A, et al.. Optimal sampling strategies for therapeutic drug monitoring of first-line tuberculosis drugs in patients with tuberculosis. Clin Pharmacokinet. 2019, 58:1445-54. 10.1007\/s40262-019-00763-3","journal-title":"Clin Pharmacokinet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s42269-023-01001-4","article-title":"Can resistance to either isoniazid or rifampicin predict multidrug resistance tuberculosis (MDR-TB)","volume":"47","author":"Mchaki BR","year":"2023","unstructured":"Mchaki BR, Mgaya FX, Kunambi PP, Matee MI. Can resistance to either isoniazid or rifampicin predict multidrug resistance tuberculosis (MDR-TB). Bul Nat Res Cent. 2023, 47:23. 10.1186\/s42269-023-01001-4","journal-title":"Bul Nat Res Cent"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jksus.2024.103133","article-title":"Comparison of short term and long term multidrug resistant tuberculosis treatment outcomes in tertiary care settings","volume":"36","author":"Munir MK","year":"2024","unstructured":"Munir MK, Saeed MS, Haider SZ, Shamim S. Comparison of short term and long term multidrug resistant tuberculosis treatment outcomes in tertiary care settings. J King Saud Uni Sci. 2024, 36:103133. 10.1016\/j.jksus.2024.103133","journal-title":"J King Saud Uni Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.743198","article-title":"Whole genome sequencing of drug resistant and drug susceptible Mycobacterium tuberculosis isolates from Tigray Region, Ethiopia","volume":"12","author":"Welekidan LN","year":"2021","unstructured":"Welekidan LN, Yimer SA, Skjerve E, Dejene TA, Homberset H, T\u00f8njum T, Brynildsrud O. Whole genome sequencing of drug resistant and drug susceptible Mycobacterium tuberculosis isolates from Tigray Region, Ethiopia. Front Microbiol. 2021, 12:743198. 10.3389\/fmicb.2021.743198","journal-title":"Front Microbiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fuz006","article-title":"Mycobacterium tuberculosis infection of host cells in space and time","volume":"43","author":"Bussi C","year":"2019","unstructured":"Bussi C, Gutierrez MG. Mycobacterium tuberculosis infection of host cells in space and time. FEMS Microbiol Rev. 2019, 43:341-61. 10.1093\/femsre\/fuz006","journal-title":"FEMS Microbiol Rev"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22705-z","article-title":"Genomic analyses of Mycobacterium tuberculosis from human lung resections reveal a high frequency of polyclonal infections","volume":"12","author":"Moreno-Molina M","year":"2021","unstructured":"Moreno-Molina M, Shubladze N, Khurtsilava I, et al.. Genomic analyses of Mycobacterium tuberculosis from human lung resections reveal a high frequency of polyclonal infections. Nat Commun. 2021, 12:2716. 10.1038\/s41467-021-22705-z","journal-title":"Nat Commun"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.35154","article-title":"Multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) among children: where we stand now","volume":"15","author":"Chowdhury K","year":"2023","unstructured":"Chowdhury K, Ahmad R, Sinha S, Dutta S, Haque M. Multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB) among children: where we stand now. Cureus. 2023, 15:e35154. 10.7759\/cureus.35154","journal-title":"Cureus"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-4817-2","article-title":"Does Xpert\u00ae MTB\/RIF assay give rifampicin resistance results without identified mutation? Review of cases from Addis Ababa, Ethiopia","volume":"20","author":"Alemu A","year":"2020","unstructured":"Alemu A, Tadesse M, Seid G, et al.. Does Xpert\u00ae MTB\/RIF assay give rifampicin resistance results without identified mutation? Review of cases from Addis Ababa, Ethiopia. BMC Infect Dis. 2020, 20:87. 10.1186\/s12879-020-4817-2","journal-title":"BMC Infect Dis"},{"key":"ref17","article-title":"Identification of missing probes in rpoB gene in rifampicin resistant PTB and EPTB cases using Xpert MTB\/RIF assay in Sirmaur, Himachal Pradesh","volume":"68","author":"Kumar V","year":"2020","unstructured":"Kumar V, Bala M, Kanga A, Gautam N. Identification of missing probes in rpoB gene in rifampicin resistant PTB and EPTB cases using Xpert MTB\/RIF assay in Sirmaur, Himachal Pradesh. J Assoc Physicians India. 2020, 68:33-6.","journal-title":"J Assoc Physicians India"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijtb.2018.08.002","article-title":"Pattern of missing probes in rifampicin resistant TB by Xpert MTB\/RIF assay at a tertiary care centre in Mumbai","volume":"66","author":"Kanade S","year":"2019","unstructured":"Kanade S, Nataraj G, Mehta P, Shah D. Pattern of missing probes in rifampicin resistant TB by Xpert MTB\/RIF assay at a tertiary care centre in Mumbai. Indian J Tuberc. 2019, 66:139-43. 10.1016\/j.ijtb.2018.08.002","journal-title":"Indian J Tuberc"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.48036\/apims.v19i2.519","article-title":"Epidemiology of molecular probes in Xpert MTB\/RIF assay in AJK, Pakistan","volume":"19","author":"Baber JZ","year":"2023","unstructured":"Baber JZ, Ali I, Qasim Z, et al.. Epidemiology of molecular probes in Xpert MTB\/RIF assay in AJK, Pakistan. Ann Pak Inst Med Sci. 2023, 19:74-80. 10.48036\/apims.v19i2.519","journal-title":"Ann Pak Inst Med Sci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.21649\/akemu.v24i1.2335","article-title":"Comparison of gene Xpert MTB\/RIF assay with conventional standard proportion method for determination of drug susceptibility in multidrug resistant TB suspects","volume":"24","author":"Munir MK","year":"2018","unstructured":"Munir MK, Rehman S, Iqbal R, Saeed MS, Aasim M. Comparison of gene Xpert MTB\/RIF assay with conventional standard proportion method for determination of drug susceptibility in multidrug resistant TB suspects. Ann King Edward Med Uni. 2018, 24:570-6. 10.21649\/akemu.v24i1.2335","journal-title":"Ann King Edward Med Uni"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.9734\/BJMMR\/2015\/16687","article-title":"Evaluate \u201crifampicin resistance\u201d as surrogate marker for rapid detection of MDR-TB using real-time PCR directly on FNAC samples of tuberculous lymphadenitis","volume":"9","author":"Raoot A","year":"2015","unstructured":"Raoot A, Dev G. Evaluate \u201crifampicin resistance\u201d as surrogate marker for rapid detection of MDR-TB using real-time PCR directly on FNAC samples of tuberculous lymphadenitis. Br J Med Med Res. 2015, 9:1-8. 10.9734\/BJMMR\/2015\/16687","journal-title":"Br J Med Med Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens12070909","article-title":"Analysis of discordance between genotypic and phenotypic assays for rifampicin-resistant Mycobacterium tuberculosis isolated from healthcare facilities in Mthatha","volume":"12","author":"Bokop C","year":"2023","unstructured":"Bokop C, Faye LM, Apalata T. Analysis of discordance between genotypic and phenotypic assays for rifampicin-resistant Mycobacterium tuberculosis isolated from healthcare facilities in Mthatha. Pathogens. 2023, 12:10.3390\/pathogens12070909","journal-title":"Pathogens"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00553-13","article-title":"Rifampin drug resistance tests for tuberculosis: challenging the gold standard","volume":"51","author":"Van Deun A","year":"2013","unstructured":"Van Deun A, Aung KJ, Bola V, et al.. Rifampin drug resistance tests for tuberculosis: challenging the gold standard. J Clin Microbiol. 2013, 51:2633-40. 10.1128\/JCM.00553-13","journal-title":"J Clin Microbiol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/ja.2014.107","article-title":"Resistance to rifampicin: a review","volume":"67","author":"Goldstein BP","year":"2014","unstructured":"Goldstein BP. Resistance to rifampicin: a review. J Antibiot (Tokyo). 2014, 67:625-30. 10.1038\/ja.2014.107","journal-title":"J Antibiot (Tokyo)"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0169798","article-title":"Diagnostic accuracy of GeneXpert MTB\/RIF assay in comparison to conventional drug susceptibility testing method for the diagnosis of multidrug-resistant tuberculosis","volume":"12","author":"Pandey P","year":"2017","unstructured":"Pandey P, Pant ND, Rijal KR, et al.. Diagnostic accuracy of GeneXpert MTB\/RIF assay in comparison to conventional drug susceptibility testing method for the diagnosis of multidrug-resistant tuberculosis. PLoS One. 2017, 12:e0169798. 10.1371\/journal.pone.0169798","journal-title":"PLoS One"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/419457-a-comparative-analysis-of-resistance-patterns-in-rifampin-resistant-tuberculosis-mutations-within-and-outside-the-rifampicin-resistance-determining-region","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T01:41:38Z","timestamp":1759801298000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/419457-a-comparative-analysis-of-resistance-patterns-in-rifampin-resistant-tuberculosis-mutations-within-and-outside-the-rifampicin-resistance-determining-region"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.93975","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,6]]}}}